A U.S. appeals court revived a lawsuit from Teva Pharmaceuticals. Teva accuses Eli Lilly of breaching a settlement related to the osteoporosis drug Forteo. The 7th U.S. Circuit Court of Appeals reversed a lower court's dismissal. It sent the case back to an Indiana federal court for further proceedings.
Teva alleges Eli Lilly violated a 2018 patent settlement. This violation involved actions that delayed the launch of Teva's generic Forteo. The dispute centers on whether the settlement terms remained in effect after Lilly's patents expired. The appeals court determined this issue could not be resolved in Lilly's favor based solely on the contract's text.